Grifols SA (GRFS)
6.375
+0.10
(+1.67%)
USD |
NASDAQ |
Apr 26, 15:49
Grifols Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2021 | -105.67M |
| March 31, 2021 | -79.83M |
| December 31, 2020 | -404.74M |
| September 30, 2020 | -364.35M |
| June 30, 2020 | -343.66M |
| March 31, 2020 | -430.63M |
| December 31, 2019 | -372.07M |
| September 30, 2019 | 8.827M |
| June 30, 2019 | 147.49M |
| March 31, 2019 | 132.78M |
| December 31, 2018 | 180.08M |
| September 30, 2018 | -229.88M |
| June 30, 2018 | -193.65M |
| March 31, 2018 | -59.63M |
| December 31, 2017 | 1.624B |
| September 30, 2017 | 1.610B |
| June 30, 2017 | 1.444B |
| March 31, 2017 | 1.363B |
| December 31, 2016 | -364.74M |
| September 30, 2016 | -236.14M |
| Date | Value |
|---|---|
| June 30, 2016 | -195.66M |
| March 31, 2016 | -189.09M |
| December 31, 2015 | -175.38M |
| September 30, 2015 | -280.24M |
| June 30, 2015 | -386.97M |
| March 31, 2015 | -453.98M |
| December 31, 2014 | 1.119B |
| September 30, 2014 | 1.339B |
| June 30, 2014 | 1.430B |
| March 31, 2014 | 1.535B |
| December 31, 2013 | -139.64M |
| September 30, 2013 | -286.62M |
| June 30, 2013 | -304.05M |
| March 31, 2013 | -281.56M |
| December 31, 2012 | -392.54M |
| September 30, 2012 | -417.88M |
| June 30, 2012 | -1.063B |
| March 31, 2012 | 1.896B |
| December 31, 2011 | 2.057B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-430.63M
Minimum
Mar 2020
147.49M
Maximum
Jun 2019
-216.07M
Average
-343.66M
Median
Jun 2020
Cash from Financing (TTM) Benchmarks
| DBV Technologies SA | 6.767M |
| Adaptimmune Therapeutics PLC | 0.88M |
| Biodexa Pharmaceuticals Plc | 12.76M |
| NuCana PLC | -0.0659M |
| Autolus Therapeutics PLC | -0.883M |